Eli Lilly’s Zepbound (Tirzepetide) has been approved by the FDA

https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

Edited November 9, 20232 yr by GreenTealael

Absolutely, the FDA's approval of Eli Lilly's Zepbound™ (tirzepatide) is a game-changer in weight management! It's the first medication that works on both GIP and GLP-1 receptors, making it a novel addition to obesity treatments.

Clinical trials have been impressive, with participants losing an average of 22.5% of their body weight. For many, this could be a transformative non-surgical alternative that might reduce or even eliminate the need for bariatric surgery.

That said, it's important to consider the potential side effects, which can be quite serious, as well as its high cost—although Eli Lilly is working to increase accessibility.

As this medication rolls out, it could redefine treatment plans, offering a new, potent tool for weight loss both before and after bariatric surgery. It's an exciting time for both patients and healthcare providers in the field of weight management!

3 minutes ago, Alex Brecher said:

Absolutely, the FDA's approval of Eli Lilly's Zepbound™ (tirzepatide) is a game-changer in weight management! It's the first medication that works on both GIP and GLP-1 receptors, making it a novel addition to obesity treatments.

Clinical trials have been impressive, with participants losing an average of 22.5% of their body weight. For many, this could be a transformative non-surgical alternative that might reduce or even eliminate the need for bariatric surgery.

That said, it's important to consider the potential side effects, which can be quite serious, as well as its high cost—although Eli Lilly is working to increase accessibility.

As this medication rolls out, it could redefine treatment plans, offering a new, potent tool for weight loss both before and after bariatric surgery. It's an exciting time for both patients and healthcare providers in the field of weight management!

Additionally with the anticipated revenue in mind, this can catapult further research and innovation. Hopefully insulin resistance, metabolic syndrome, obesity and their related comorbidities can be cured in our lifetime.

14 hours ago, GreenTealael said:

Eli Lilly’s Zepbound (Tirzepetide) has been approved by the FDA

https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

A big no thanks for me!!! Not a fan of drugs that can cause many other issues including some serious ones. It is nice however to see that obesity is being taken seriously as a disease that needs to be treated. It is also nice to see trials being done for obesity. I'm not a fan of this drug nor ozempic as they could have some serious side effects. I hope they come up with something else without all these potentially serious side effects.

2 hours ago, NCL04321 said:

A big no thanks for me!!! Not a fan of drugs that can cause many other issues including some serious ones. It is nice however to see that obesity is being taken seriously as a disease that needs to be treated. It is also nice to see trials being done for obesity. I'm not a fan of this drug nor ozempic as they could have some serious side effects. I hope they come up with something else without all these potentially serious side effects.

Absolutely! The point is now there are more choices for the wider population. Many of the patients that qualified for WLS will never pursue it. They are no longer left without an effective option.